SPOKANE, Wash., Aug. 22, 2025 (GLOBE NEWSWIRE) -- TWOPAGES, a specialized custom window-treatment brand known for its design innovation, today announced the expansion of its Collaboration Program, a ...
Spready株式会社(本社:東京都渋谷区、代表取締役社長:佐古雅亮、以下、当社)は、1月23日より、企業の人を探したいというニーズに対して、紹介したユーザーと紹介されたユーザーが、信頼の対価として、協賛企業の提供するサービスを受け取ることが ...
クラウドを活用した働き方改革をより多くの企業様へ。G Suite 認定トレーナーによる最新 G Suite 活用レクチャーを1アカウント初年度720円・2年目以降360円の定額で提供。 1000社を超えるアンケートの結果、G Suiteを導入した企業のうち7割の方が「G Suiteは導入 ...
【Industry】Nissan Chemical Industries, Ltd. Christian KOOS(Professor, Karlsruhe Institute of Technology) 【Academia】Karlsruhe Institute of Technology 【Industry】Vanguard Automation GmbH This proposal ...
It has been six years since the launch of the Ministry of SMEs and Startups (MSS, Minister OH Youngju) 's flagship public-private collaboration startup support initiative, the 'Collaboration Program ...
Youth entrepreneurship programs have multiplied over the past decade. High schools now offer entrepreneurship education in the form of curriculum and business electives, college campuses host student ...
On January 30, the Ministry of SMEs and Startups (MSS, Minister OH Youngju) held a meeting with thirteen startups that will participate in a collaborative program with OpenAI, a global leader in AI ...
HARTFORD, Conn., Sept. 22, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announced it will scale the Aetna Clinical Collaboration (ACC) program to ten hospitals by year-end, ...
株式会社セゾン情報システムズ(本社:東京都豊島区、代表取締役社長:内田 和弘、以下、セゾン情報システムズ)は、「HULFT Partner Program(HPP)」を拡張した「HULFTコラボレーション」を2017年4月1日より提供開始し、本プログラムに新興著しいクラウド領域の ...
Aetna, a CVS Health company, announced it will scale the Aetna Clinical Collaboration program to 10 hospitals by year-end, with implementations underway with AdventHealth Shawnee Mission, Houston ...
Over the past year, Chengdu and Chongqing in Southwest China have completed a total of 67 major collaboration programs, achieving 103.09 billion yuan ($16.29 billion) in investment, according to news ...
Ideaya Biosciences, Inc. (NASDAQ:IDYA) announced Thursday that GlaxoSmithKline Intellectual Property (No. 4) has elected to terminate the Collaboration, Option and License Agreement dated June 15, ...